Expression of the metalloproteases MMP-1, MMP-2, MMP-3, MMP-9, MMP-11, TIMP-1 and TIMP-2 in angiocentric midfacial lymphomas

被引:6
|
作者
Meneses-García A. [1 ]
Betancourt A.M. [1 ]
Abarca J.H. [2 ]
Montes A.B. [2 ]
Roa L.S. [1 ]
Ruíz-Godoy L. [3 ]
机构
[1] Pathology Department, Instituto Nacional de Cancerología
[2] Pharmacology Department, Instituto Politécnico Nacional
[3] Basic Research, Instituto Nacional de Cancerología
关键词
Nasal Cavity; Neoplastic Cell; Blood Vessel Wall; Extranodal Lymphoma; Cytotoxic Granule;
D O I
10.1186/1477-7819-6-114
中图分类号
学科分类号
摘要
Background: Extranodal T/NK cell lymphomas possess distinctive clinico-pathological characteristics: they are angiocentric, exhibit extensive necrosis. Prognosis is poor in the short term. The objective is to explore the expression of different MMPs in the cells and stroma which are around of the blood vessels damaged and their correlation with clinico-pathological parameters. Patients and methods: Twenty cases of this type of lymphomas were studied and collected patient clinical data. The expressions of MMP-1, 2, 3, 9, 11, 13 and TIMP-1, 2 were studied by immunohistochemistry. Ultrastructural studies were performed in two cases. Statistical analysis was done with Fisher's exact test, Chi2 test. Results: Of the 20 patients, 13 were men with median age of 43 years. In 13 patients the primary tumor was localized in the nasal cavity. Treatment was combined chemotherapy and radiotherapy in 60%. The 55% advanced clinical stages, 70% died from the disease. There were neoplastic cell and peritumoral fibroblasts positivity to MMP-1 and MMP-11 in most of the cases. The MMPs-2, 3 and 9 were expressed in neoplastic cell between 30 to 65%of the cases. TIMP-1 was presented mainly in the epithelium and TIMP-2 was poor expressed of the all cases. Conclusion: There were no statistical significance between the different enzymes used and the clinical parameters, besides status and survival of the patients. It is necessary to study more enzymes and focus them to quantify and determine their activity, in order to have a better correlation with histological features in this type of neoplasm. © 2008 Meneses-García et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 50 条
  • [21] Expression of Matrix Metalloproteinases (MMP-2, MMP-9) and their Inhibitors (TIMP-1, TIMP-2) in Canine Testis, Epididymis and Semen
    Warinrak, C.
    Wu, J-T
    Hsu, W-L
    Liao, J-W
    Chang, S-C
    Cheng, F-P
    REPRODUCTION IN DOMESTIC ANIMALS, 2015, 50 (01) : 48 - 57
  • [22] The expression of MMP-2, MMP-7, MMP-9, and TIMP-1 in chronic rhinosinusitis and nasal polyposis
    Can, Ilknur Haberal
    Ceylan, Kursat
    Caydere, Muzaffer
    Samim, Ethem Erdal
    Ustun, Huseyin
    Karasoy, Durdu Sertkaya
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2008, 139 (02) : 211 - 215
  • [23] MMP-2, MMP-9/TIMP-1, TIMP-2 immunophenotype identifies clinical outcome in gastric cancer patients
    Halon, A.
    Donizy, P.
    Halon, L.
    Rudno-Rudzinska, J.
    Kielan, W.
    Rabczynski, J.
    VIRCHOWS ARCHIV, 2010, 457 (02) : 252 - 253
  • [24] Decreases in plasma MMP-2/TIMP-2 and MMP-9/TIMP-1 ratios in uremic patients during hemodialysis
    Li-Che Lu
    Chung-Wei Yang
    Wen-Yeh Hsieh
    Wan-Hsuan Chuang
    Yi-Chang Lin
    Chih-Sheng Lin
    Clinical and Experimental Nephrology, 2016, 20 : 934 - 942
  • [25] Serum metalloproteinases MMP-2, MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in patients on hemodialysis
    Rysz, Jacek
    Banach, Maciej
    Stolarek, Robert A.
    Mikhailidis, Dimitri P.
    Cialkowska-Rysz, Aleksandra
    Pokoca, Lech
    Piechota, Mariusz
    Baj, Zbigniew
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2011, 43 (02) : 491 - 498
  • [26] Relationships between MMP-2, MMP-9, TIMP-1 and TIMP-2 levels and their pathogenesis in patients with lupus nephritis
    Jiang, Zhongxin
    Sui, Tao
    Wang, Bin
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (09) : 1219 - 1226
  • [27] Serum metalloproteinases MMP-2, MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in patients on hemodialysis
    Jacek Rysz
    Maciej Banach
    Robert A. Stolarek
    Dimitri P. Mikhailidis
    Aleksandra Cialkowska-Rysz
    Lech Pokoca
    Mariusz Piechota
    Zbigniew Baj
    International Urology and Nephrology, 2011, 43 : 491 - 498
  • [28] MMP-2、MMP-9及其抑制剂TIMP-2、TIMP-1与肾脏疾病
    童桂霞
    胡晓晶
    柳方娥
    国际儿科学杂志, 2011, (04) : 416 - 419
  • [29] Relationships between MMP-2, MMP-9, TIMP-1 and TIMP-2 levels and their pathogenesis in patients with lupus nephritis
    Zhongxin Jiang
    Tao Sui
    Bin Wang
    Rheumatology International, 2010, 30 : 1219 - 1226
  • [30] Study of MMP-2, MMP-9, TIMP-1 and TIMP-2 in peripheral blood of differentiated thyroid carcinoma patients
    Zhang, W. J.
    Song, B.
    Wang, C.
    Yang, T.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 124 : 38 - 39